All news from Dermatology

FDG-PET/CT: Lesion Glycolysis In Patients With Lymphoma

Whether baseline metabolic tumor volume (TMTV) and total lesion glycolysis (TLG) measured by FDG-PET/CT affected prognosis of patients with lymphoma was controversial. We searched PubMed, EMBASE and Cochrane to identify studies assessing the effect of baseline TMTV and TLG on the survival of lymphoma patients. Pooled hazard ratios (HR) for overall survival (OS) and progression-free survival (PFS) were calculated, along with 95% confidence intervals (CI). 

Early Birth Linked To Lower Education In Adulthood

Early term babies may be less likely than infants born full term to eventually earn a college degree and get a high-paying job, a large study suggests. In the analysis of 228,030 singleton births in Denmark, infants who were born after only 38 weeks of pregnancy were 15% less likely than those born at 40 weeks to have some education beyond high school or to be among the top earners in the study.

Vaginal Ring Pessary Suitable For Use In Pelvic-Organ

A vaginal ring pessary with support for alleviate symptoms of advanced pelvic organ prolapse (POP) for three years or longer, according to a new study. Further, a majority of patients in the study (61.7%) would still be using the pessary after five years, for Kaplan-Meier analysis, Dr. Sirarat Sarit-apirak of Mahidol University, in Bangkok, and colleagues report in Menopause, online December 17.

Study: Drug May Delay MS Disability For Some

An immune system drug may help prevent or delay in a type of multiple sclerosis known as secondary progressive MS, a new study finds.The medication is called rituximab (Rituxan). It's used to treat a number of conditions, including certain blood cell cancers and the autoimmune condition rheumatoid arthritis.

Study: Contraceptive Posters Improve Knowledge

Even brief exposure to educational posters that clearly describes different contraception options and their reliability is effective in boosting women's understanding of the issues, and a new patient-centered poster appears even better than a standard poster issued by the Centers for Disease Control and Prevention (CDC ), according to a new randomized study.